We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA's Critical Path Initiative Centers on Clinical Trials and Biomarkers
FDA's Critical Path Initiative Centers on Clinical Trials and Biomarkers
March 22, 2006
The FDA’s Critical Path Opportunities List, unveiled March 16, focuses on projects intended to streamline clinical trials and advance the use of biomarkers.